Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.
Cancer Discov. 2024 May 1;14(5):727-736. doi: 10.1158/2159-8290.CD-23-1138.
Cancer Discov. 2024.
PMID: 38236605
Free PMC article.
Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic Response.
Eluri M, Kopetz S, Parseghian CM.
Eluri M, et al.
Clin Cancer Res. 2023 Jan 17;29(2):302-304. doi: 10.1158/1078-0432.CCR-22-2793.
Clin Cancer Res. 2023.
PMID: 36378102
Free PMC article.
Item in Clipboard
KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy.
Ryan MB, Coker O, Sorokin A, Fella K, Barnes H, Wong E, Kanikarla P, Gao F, Zhang Y, Zhou L, Kopetz S, Corcoran RB.
Ryan MB, et al.
Cell Rep. 2022 Jun 21;39(12):110993. doi: 10.1016/j.celrep.2022.110993.
Cell Rep. 2022.
PMID: 35732135
Free PMC article.
Item in Clipboard
Cite
Cite